Open AccessAssociation Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries
Author(s) -
Guillaume Fond,
Katlyn Nemani,
Damien EtchecoparEtchart,
Anderson Loundou,
Donald Goff,
Seung Won Lee,
Christophe Lançon,
Pascal Auquier,
Karine Baumstarck,
PierreMichel Llorca,
Dong Keon Yon,
Laurent Boyer
Publication year - 2021
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2021.2274
Subject(s) - psychiatry , mental health , medicine , anxiety , population , mood disorders , alcohol use disorder , major depressive disorder , bipolar disorder , schizophrenia (object oriented programming) , prevalence of mental disorders , alcohol abuse , mood , comorbidity , substance abuse , mental illness , borderline personality disorder , environmental health , biochemistry , chemistry , alcohol
Heterogeneous evidence exists for the association between COVID-19 and the clinical outcomes of patients with mental health disorders. It remains unknown whether patients with COVID-19 and mental health disorders are at increased risk of mortality and should thus be targeted as a high-risk population for severe forms of COVID-19.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom